What is the Adagio Therapeutics, Inc. stock price forecast?

Adagio Therapeutics, Inc. is currently trading at $1.78. View real-time AI analysis on Alpha Lenz.

What is Adagio Therapeutics, Inc. insider trading activity?

View the latest insider trading data for Adagio Therapeutics, Inc. on Alpha Lenz.

What is Adagio Therapeutics, Inc.'s P/E ratio?

Adagio Therapeutics, Inc.'s P/E ratio is -0.3.

Adagio Therapeutics, Inc.

NASDAQ · ADGI

$1.78

Ask about Adagio Therapeutics, Inc.'s future dividend policy...

Alpha Chat Insight

“Adagio Therapeutics, Inc. trades at a P/E of -0.3 (undervalued) with strong ROE of 126.9%.”

Ask for details →

Company Overview

Websitehttps://adagiotx.com

SectorUnknown

IndustryUnknown

Company Statistics

FY 2021

Profile

$75.87MMarket Cap

$0.00Revenue

0.00Shares Out

0Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

-0.33P/E

-0.26P/B

N/AEV/Sales

2.20EV/EBITDA

-0.41P/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-61.50%ROA

126.90%ROE

127.76%ROIC

Financial Health

$542.22MCash & Cash Equivalents

$-536.43MNet Debt

-1.98%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Adagio Therapeutics, Inc. trades at a P/E of -0.3 (undervalued) with strong ROE of 126.9%.”

Ask for details →

Frequently Asked Questions

Adagio Therapeutics, Inc. (ticker: ADGI) is a company listed on NASDAQ in the Unknown sector (Unknown). Market cap is $76M.

The current price is $1.78 with a P/E ratio of -0.33x and P/B of -0.26x.

ROE is 126.90%.